XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Note 10 - Acquisition of Irwin Naturals
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Business Combination [Text Block]

NOTE 10 – ACQUISITION OF IRWIN NATURALS

 

On August 8, 2025 (“the Closing Date”), the Company acquired substantially all of the assets and assumed certain liabilities of Irwin through an asset purchase transaction under Section 363 of the US Bankruptcy Code. Total consideration for the acquisition was approximately $42,500.  Of this amount, $29,750 was funded using proceeds from a new term loan provided by the Bank and $6,000 was funded from a new $10,000 revolving line of credit from the Bank, with the remainder funded from the Company’s available cash balances. The Company is in the process of determining the fair value of the tangible and intangible assets of Irwin. 

 

During the three and nine months ended September 30, 2025, the Company incurred $820 and $1,848, respectively, of transaction-related costs for the acquisition of Irwin.

 

The Company accounted for the acquisition as a business combination under Accounting Standards Codification (“ASC”) 805, Business Combinations. At the date of the acquisition and as of this Quarterly Report on Form 10-Q, management has not yet finalized its valuation analysis. The fair values of the intangible assets acquired, as set forth below, are considered provisional and subject to adjustment as additional information is obtained through the purchase price measurement period (a period of up to one year from the Closing Date). Any prospective adjustments would change the fair value allocation as of the acquisition date. The Company is still in the process of reviewing underlying models, assumptions and discount rates used in the valuation of provisional goodwill and intangible assets. The following table summarizes the fair value of the assets acquired and liabilities assumed on the date of acquisition, and is as follows:

 

   

August 8, 2025

 
         

Accounts receivable

  $ 7,306  

Inventories

    10,754  

Prepaid expense and other current assets

    355  

Right of use asset

    487  

Property and equipment

    69  

Intangible assets (provisional)

    25,500  

Goodwill (provisional)

    6,288  

Other non-current assets

    83  

Accounts payable and accrued expense

    (2,056 )

Accrued expense and other current liabilities

    (5,240 )

Product returns

    (533 )

Lease liabilities

    (513 )

Net assets acquired

  $ 42,500  

 

The purchase was intended to augment and diversify the Company’s product offerings and lineup.  Key factors that contributed to the recorded intangible assets and goodwill were the opportunity to complement existing operations of the Company and the opportunity to generate future synergies within the nutritional supplement and wellness business.

 

Pro Forma Condensed Combined Financial Information (Unaudited) (In thousands)

 

The following presents the Company’s unaudited pro forma financial information for the nine months ended September 30, 2025 and 2024, respectively, giving effect to the acquisition of Irwin as if it had occurred at January 1, 2024. Included in the pro forma information is: fair value adjustment to inventory acquired,  transaction-related costs related to the acquisition of Irwin moved from the nine months ended September 30, 2025 to the nine months ended September 30, 2024, removal of the interest costs from the Company’s debt prior to the closing of the acquisition, and interest on borrowings made by the Company based on the projected balance of the Irwin Term Loan for the respective periods in this pro forma presentation.

 

   

Nine months ended

 
   

September 30, 2025

   

September 30, 2024

 
                 

Revenue

  $ 96,918     $ 105,708  
                 

Net income

  $ 8,389     $ 8,154  
                 

Diluted net income per share

  $ 0.84     $ 0.82  

-

The pro forma adjustments do not reflect adjustments for anticipated operating efficiencies that the Company expects to achieve as a result of this acquisition. The pro forma financial information is for informational purposes only and does not purport to present what the Company’s results would actually have been had the transaction actually occurred on the dates presented or to project the combined company’s results of operations or financial position for any future period.

 

Irwin revenue and net income from August 8, 2025 through September 30, 2025 were $6,821 and $504, respectively.